Ursofalk, Kapseln

7680427820257 CH-42782 Kapseln

Associated product:

URSOFALK caps 250 mg 50 pce
Ursofalk, Kapseln
Ursofalk, Kapseln
Ursofalk, Kapseln
1 / 3
google

Article details

Package size
50
Selling units
50
Measure
Kapsel(n)
Galenic form
Kapseln
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
29/04/2025
Patient information leaflet
Français
29/04/2025
Patient information leaflet
Italien
29/04/2025
Summary of Product Characteristics
Allemand
29/04/2025
Summary of Product Characteristics
Français
29/04/2025
Summary of Product Characteristics
Italien
29/04/2025

Detailed composition

Substance Quantity Type Category
(N/A)
250.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
0.016 MG Substance HBESI

Reimbursement information

Public price
CHF 42.85
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 15/03/1982

Authorization holder

Dr. Falk Pharma AG

8152 Opfikon

Authorization information

Swissmedic authorization number
42782
Drug name
Ursofalk, Kapseln
Galenic form
KAPS
ATC Code
A05AA02
Authorization status
Z
Dispensing category
B
First authorization
06/08/1980
Authorization expiration date
31/12/9999
IT Number
04.99.0.
Domain
Human medicine
Field of application
Auflösung von Gallensteinen

Package details

Description (FR)
URSOFALK caps 250 mg 50 pce
Description (DE)
URSOFALK Kaps 250 mg 50 Stk
Market launch
06/08/1980
Narcotic (BTM)
No

Other package sizes (1)

URSOFALK caps 250 mg 100 pce
100 KAP
GTIN: 7680427820332
View